Polymorphisms in transporter genes and chemotherapy response in acute myeloid leukemia (AML) patients from Israel

被引：0
|
作者：
Risch, A
Müller, P
Asher, N
Bar-Cohen, S
Bartsch, H
Rund, D
机构：
[1] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2006年 / 372卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
561
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [41] Personalized and Optimized Low-Dose and Intensive Chemotherapy Treatments for Patients with Acute Myeloid Leukemia (AML)
    Quiroga-Campano, Ana Luz
    Enfield, Louise
    Foster, Matthew
    Kostoglou, Margaritis
    Georgiadis, Michael
    Mantalaris, Athanasios
    Panoskaltsis, Nicki
    BLOOD, 2018, 132
  • [42] Chemotherapy as Treatment for Acute Myeloid Leukemia (AML)-Induced Facial Nerve Palsy
    Fana, Michael
    Centofanti, Brook
    Kuriakose, Philip
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [43] Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)
    Nolt, Dawn
    Lindemulder, Susan
    Meyrowitz, Jeffrey
    Chang, Bill H.
    Malempati, Suman
    Thomas, Gregory
    Stork, Linda
    PEDIATRIC BLOOD & CANCER, 2015, 62 (07) : 1149 - 1154
  • [44] Natural Killer Cells Recovery After Consolidation Chemotherapy in Elderly Patients with Acute Myeloid Leukemia (AML)
    Rey, Jerome
    Anfossi, Nicolas
    Andre, Pascale
    Boher, Jean-Marie
    Orlanducci, Florence
    Breso, Violette
    Perri, Valentine
    Prebet, Thomas
    Charbonnier, Aude
    Perrot, Eloise
    Romagne, Francois
    Vey, Norbert
    Olive, Daniel
    BLOOD, 2011, 118 (21) : 955 - 956
  • [45] Patterns of Undertreatment Among Patients with Acute Myeloid Leukemia (AML) Not Receiving Standard Intensive Induction Chemotherapy
    Hubscher, Elizabeth
    Sikirica, Slaven
    Bell, Timothy J.
    Brown, Andrew
    Welch, Verna L.
    Russell-Smith, Alexander
    D'Amico, Paul G.
    BLOOD, 2020, 136
  • [46] VITAMIN C DEFICIENCY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Ottone, T.
    Faraoni, I.
    Fucci, G.
    Divona, M.
    De Bellis, E.
    Marchesi, F.
    Angelini, D. F.
    Palmieri, R.
    Gurnari, C.
    Giansanti, M.
    Nardozza, A. M.
    Montesano, F.
    Travaglini, S.
    Puzzangara, M. C.
    De Angelis, G.
    Cicconi, L.
    De Bardi, M.
    Battistini, L.
    Massoud, R.
    Venditti, A.
    Voso, M. T.
    HAEMATOLOGICA, 2021, 106 (10) : 96 - 97
  • [47] Survival Analysis of Adult Patients with Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy: Results of a Mexican National AML Registry
    Demichelis, Roberta
    Zapata, Nidia
    Leyto, Faustino
    Terreros, Eduardo
    Carrillo, Angel
    Montano, Efreen
    Carlos Solis, Juan
    Colunga, Perla
    Diaz, Guillermo
    Amador, Fabian
    Martinez, Ramon
    Turrubiates, Francisco
    Cabrera, Alvaro
    Zaragoza, Alva
    Espinoza, Ramiro
    Gutierrez, Ruth
    Apodaca, Elia
    Moreira, Carolina
    Garcia, Carolina
    Garcia, Lilia
    Limon, Alejandro
    Gomez, David
    Rozen, Etta
    Espinosa, Karla
    Crespo, Erick
    Meillon, Luis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S209 - S210
  • [48] AML THERAPY: IS AZACYTIDINE AN ALTERNATIVE TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKEMIA? A RETROSPECTIVE STUDY ON 334 OLDER AML PATIENTS
    Bories, Pierre
    ANNALS OF HEMATOLOGY, 2013, 92 : S4 - S4
  • [49] DIFFERENTIAL EXPRESSION OF MYELOID LINEAGE TYROSINE KINASE GENES IN ACUTE MYELOID-LEUKEMIA (AML)
    LONGACRE, T
    DRESSLER, L
    WILLMAN, C
    MODERN PATHOLOGY, 1988, 1 (01) : A57 - A57
  • [50] STAT5 gene polymorphisms are associated with the response of acute myeloid leukemia patients to Ara-C-based chemotherapy
    Xu, Peipei
    Zhou, Di
    Ouyang, Jian
    Chen, Bing
    LEUKEMIA & LYMPHOMA, 2016, 57 (04) : 921 - 926
12345